Abstract
Dr Chris Jackson, oncologist and Medical Director of the Cancer Society of New Zealand, presenting 'Keytruda, from bench to bedside - The challenge of getting a breakthrough drug to New Zealanders' at the public seminar 'Cancer: Where We’re At… Research, Therapy and Access' jointly hosted by the Cancer Society Otago & Southland Division in Queenstown on 4 November 2017.